Tuberculosis Trial, Recruiting (NCT05916638)

Tuberculosis Trial, Recruiting NCT05916638 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Tuberculosis

Printed from Voxsanity (voxsanity.com.au) — NCT05916638 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Tuberculosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are older than 18 years of age, either male or female
People who have been diagnosed with both sarcoidosis and tuberculosis
People who are covered by medical insurance

Who may not be able to join:

People who have an HIV infection
Women who are pregnant or breastfeeding
People who are under legal protection, guardianship, or have a court-appointed curator managing their affairs
People who have not signed a consent form to participate
People whose granulomatosis (a type of inflammation involving clusters of immune cells) is ultimately found to be caused by something other than sarcoidosis or tuberculosis

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Karim SACRE, MD-PhD, PU-PH, Assistance Publique - Hôpitaux de Paris

Phone: 0140256019

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05916638

Sponsor: Assistance Publique - Hôpitaux de Paris

Phase: Not Applicable

Status: Recruiting

Condition: Tuberculosis

Trial contact: 0140256019

More information: https://clinicaltrials.gov/study/NCT05916638

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are older than 18 years of age, either male or female
People who have been diagnosed with both sarcoidosis and tuberculosis
People who are covered by medical insurance

Who may not be able to join:

People who have an HIV infection
Women who are pregnant or breastfeeding
People who are under legal protection, guardianship, or have a court-appointed curator managing their affairs
People who have not signed a consent form to participate
People whose granulomatosis (a type of inflammation involving clusters of immune cells) is ultimately found to be caused by something other than sarcoidosis or tuberculosis

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Assistance Publique - Hôpitaux de Paris

Registry

ClinicalTrials.gov

Start date

15 January 2024

Est. completion

1 January 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

macrophage activation in sarcoidosis measured by epigenomic; monocyte activation in sarcoidosis measured by epigenomic; macrophage activation in sarcoidosis measured by spatial transcriptomics; monocyte activation in sarcoidosis measured by spatial transcriptomics; monocyte activation in sarcoidosis measured by transcriptomic; macrophage activation in sarcoidosis measured by transcriptomic; macrophage activation in sarcoidosis measured by cytokine measurement; monocyte activation in sarcoidosis measured by cytokine measurement

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov